Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-12

Clinical Trial Update: The GoodNEWS Lifestyle Enhancement Program [NA]

View source ↗

Summary

The GoodNEWS Lifestyle Enhancement Program trial has completed and studied a lifestyle intervention for cardiovascular disease, hypertension, diabetes mellitus,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Cardiovascular Disease, Hypertension | NA | Status: COMPLETED